BioCentury
ARTICLE | Company News

SGP's desloratadine approved in Europe

January 16, 2001 8:00 AM UTC

Schering-Plough (SGP) received European marketing approval for desloratadine long-acting nonsedating antihistamine to treat seasonal allergic rhinitis. The product, which was licensed from Sepracor (S...